GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (STU:2QA) » Definitions » Accumulated other comprehensive income (loss)

Altamira Therapeutics (STU:2QA) Accumulated other comprehensive income (loss) : €0.19 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Altamira Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Altamira Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was €0.19 Mil.

Altamira Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 (€0.13 Mil) to Jun. 2023 (€0.89 Mil) but then declined from Jun. 2023 (€0.89 Mil) to Dec. 2023 (€0.19 Mil).

Altamira Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.13 Mil) and increased from Dec. 2022 (€0.13 Mil) to Dec. 2023 (€0.19 Mil).


Altamira Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Altamira Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics Accumulated other comprehensive income (loss) Chart

Altamira Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 0.06 0.06 0.13 0.19

Altamira Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 - 0.13 0.89 0.19

Altamira Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Altamira Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Altamira Therapeutics (STU:2QA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (STU:2QA) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
2 Church Street, Clarendon House, Hamilton, BMU, HM11
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics (STU:2QA) Headlines

No Headlines